Related Experiment Video
Updated: Aug 16, 2026
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
Paraesophageal lymph node metastasis from prostatic adenocarcinoma in a patient with esophageal squamous carcinoma
J O Larkin1, C G Collins, S T Martin
1Cork Cancer Research Centre and Department of Surgery, Mercy University Hospital, Cork, Ireland.
Abstract:
SUMMARY. Esophageal squamous carcinomas induce regional immune suppression in the domain of the tumor while the global immune system remains intact. We report a patient with a squamous esophageal carcinoma, who was discovered at esophagectomy to have paraesophageal lymph node metastases from a prostatic adenocarcinoma. No other sites of metastatic disease were identified. This supports the concept that regional immune suppression by esophageal squamous cancers facilitates growth of metastases in the local lymph nodes.
Insights
Esophageal squamous cell carcinoma causes local immune suppression, allowing nearby metastases to grow. A patient with esophageal cancer also had prostate cancer spread to nearby lymph nodes, supporting this theory.
Area of Science:
- Oncology
- Immunology
Background:
- Esophageal squamous cell carcinoma (ESCC) is known to induce a localized immunosuppressive tumor microenvironment.
- The systemic immune system's response in patients with ESCC is typically preserved.
Observation:
- A patient diagnosed with ESCC was found during surgery to have paraesophageal lymph node metastases originating from a separate prostatic adenocarcinoma.
- No other distant metastatic sites were detected in this patient.
Findings:
- The presence of both ESCC and unexpected prostatic adenocarcinoma metastases in regional lymph nodes supports the hypothesis of tumor-induced immune modulation.
- Regional immune suppression by ESCC may create a permissive environment for the growth of unrelated metastases in adjacent lymph nodes.
Implications:
- This case highlights the complex interplay between different cancer types and the regional immune system.
- Understanding localized immune suppression could lead to novel therapeutic strategies targeting the tumor microenvironment to prevent or treat metastasis.
